
Higher risk of serious infection found with adalimumab and infliximab compared with nonmethotrexate and nonbiologic therapies.

Higher risk of serious infection found with adalimumab and infliximab compared with nonmethotrexate and nonbiologic therapies.

Food additive induces cells to make protective antioxidants and make repairs.

Catch up with the latest developments across the health care landscape and sign up for key upcoming conferences.

Complications from conditions such as rheumatoid arthritis and lupus may cause cardiovascular problems.

Precision medicine and immune oncology transform cancer treatment.

Research explores how HIV is able to evolve during antiretroviral therapy.

Empliciti is an immunostimulatory antibody that targets the Signaling Lymphocyte Activation Molecule Family member 7.

Most read articles of the week on Specialty Pharmacy Times.

Optogenetics technique harnesses immune system to reduce tumor size and metastasis.

Predictors of poor medication adherence include increased regimen complexity, multiple comorbidities, and high medication cost.

Rapid intervention helps patient with hepatitis C avoid cirrhosis, carcinoma, and end-stage liver disease.

Study finds the greatest access to cost-sharing reduction subsidies translated to the lowest costs for patients with HIV.

Updated guidelines seek to decrease the risk of residual exposure to potentially dangerous medications.

CVS program indicates option of in-store pickup or home delivery improved adherence rates.

Treatment delivers miRNA to late-stage liver cancer tumors with low toxicity.

Supplementing insulin therapy combined with other glucose lowering agents may improve outcomes for T1DM patient.

Study estimates cancer will cause an economic burden of $8.3 trillion worldwide from 2011 to 2030.

A US Senate committee recently held a hearing to investigate the culprits behind the growing backlog of generic drug applications at the FDA.

A patient discusses her courageous battle with familial amyotrophic lateral sclerosis.

Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how expensive hepatitis C drugs have impacted the specialty landscape.

Women diagnosed with malignant melanoma during pregnancy or within 1 year of giving birth were 5.1 times as likely to die.

Study indicates nearly 12,000 deaths related to the liver could be prevented from routine HCV screenings.

Improved colon cancer survival rate attributed to more aggressive treatment.

Dinutuximab is the first immunotherapy approved for the treatment of a pediatric cancer.

Afatinib showed significant improvement in progression-free survival and objective response rate in non-small cell lung cancer patients.

Researchers seek to determine the ideal duration between radiation treatment and the actual surgical removal of cancerous cells.

Nisin shows promise in killing cancer and deadly bacteria resistant to antibiotics.

Over the past 2 years, about 36 cases of acute hepatitis C virus infection were reported at 19 different hemodialysis clinics.

Annatto is commonly found in the seeds of the achiote fruit.

A former Walmart pharmacist was awarded around $31.2 million from her ex-employer after a federal jury decided that she was fired because of her gender and her concerns with understaffing and training.